Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Natural History and Growth Patterns of Incidentally Discovered Diffusely Infiltrating Low-Grade Gliomas: A Volumetric Study.

Opoku-Darko M, Eagles ME, Cadieux M, Isaacs AM, Kelly JJP.

World Neurosurg. 2019 Sep 7. pii: S1878-8750(19)32402-7. doi: 10.1016/j.wneu.2019.08.235. [Epub ahead of print]

PMID:
31505287
2.

Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis.

Zhang ZY, Chan AK, Ng HK, Ding XJ, Li YX, Shi ZF, Zhu W, Zhong P, Wang Y, Mao Y, Yao Y, Zhou LF.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):8627-36. eCollection 2014.

3.

Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas.

Hashiba T, Hashimoto N, Izumoto S, Suzuki T, Kagawa N, Maruno M, Kato A, Yoshimine T.

J Neurosurg. 2009 Apr;110(4):675-84. doi: 10.3171/2008.8.JNS08481.

PMID:
19061353
4.

Natural history and surgical management of incidentally discovered low-grade gliomas.

Potts MB, Smith JS, Molinaro AM, Berger MS.

J Neurosurg. 2012 Feb;116(2):365-72. doi: 10.3171/2011.9.JNS111068. Epub 2011 Oct 14.

PMID:
21999317
5.

Treatment of incidentally discovered low-grade gliomas: "watch-and-wait" or not?

Yao Y, Zhou LF.

World Neurosurg. 2013 Nov;80(5):e121-2. doi: 10.1016/j.wneu.2012.10.022. Epub 2012 Oct 24. No abstract available.

PMID:
23103272
6.

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, Bauchet L, Peruzzi P, Frénay M, Colin P, Guillevin R, Bernier V, Baron MH, Guyotat J, Duffau H, Taillandier L, Capelle L.

Neuro Oncol. 2013 May;15(5):595-606. doi: 10.1093/neuonc/nos331. Epub 2013 Feb 7.

7.

Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient.

Cochereau J, Herbet G, Rigau V, Duffau H.

J Neurosurg. 2016 Jan;124(1):141-5. doi: 10.3171/2014.12.JNS141851. Epub 2015 Jul 10.

PMID:
26162036
8.

Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.

Gozé C, Blonski M, Le Maistre G, Bauchet L, Dezamis E, Page P, Varlet P, Capelle L, Devaux B, Taillandier L, Duffau H, Pallud J.

Neuro Oncol. 2014 Aug;16(8):1100-9. doi: 10.1093/neuonc/nou085. Epub 2014 May 20.

9.

Natural history of de novo High Grade Glioma: first description of growth parabola.

Altieri R, Hirono S, Duffau H, Ducati A, Fontanella M, LA Rocca G, Melcarne A, Panciani PP, Spena G, Garbossa D.

J Neurosurg Sci. 2017 Jul 26. doi: 10.23736/S0390-5616.17.04067-X. [Epub ahead of print]

PMID:
28748908
10.

Tumor growth dynamics in serially-imaged low-grade glioma patients.

Gui C, Kosteniuk SE, Lau JC, Megyesi JF.

J Neurooncol. 2018 Aug;139(1):167-175. doi: 10.1007/s11060-018-2857-x. Epub 2018 Apr 9.

PMID:
29633111
11.

The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Fouke SJ, Benzinger T, Gibson D, Ryken TC, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):457-79. doi: 10.1007/s11060-015-1908-9. Epub 2015 Nov 3. Review.

PMID:
26530262
12.

Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.

Mert A, Kiesel B, Wöhrer A, Martínez-Moreno M, Minchev G, Furtner J, Knosp E, Wolfsberger S, Widhalm G.

Neurosurg Focus. 2015 Jan;38(1):E4. doi: 10.3171/2014.10.FOCUS14597.

PMID:
25552284
13.

The management of incidental low-grade gliomas using magnetic resonance imaging: systematic review and optimal treatment paradigm.

Shah AH, Madhavan K, Heros D, Raper DM, Iorgulescu JB, Lally BE, Komotar RJ.

Neurosurg Focus. 2011 Dec;31(6):E12. doi: 10.3171/2011.9.FOCUS11219. Review.

PMID:
22133169
14.

Low-grade gliomas in children: tumor volume response to radiation.

Fisher BJ, Bauman GS, Leighton CE, Stitt L, Cairncross JG, Macdonald DR.

J Neurosurg. 1998 Jun;88(6):969-74.

PMID:
9609290
15.

Natural history of incidental World Health Organization grade II gliomas.

Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L.

Ann Neurol. 2010 Nov;68(5):727-33. doi: 10.1002/ana.22106.

PMID:
21031584
16.

Correlation of volumetric growth and histological grade in 50 meningiomas.

Soon WC, Fountain DM, Koczyk K, Abdulla M, Giri S, Allinson K, Matys T, Guilfoyle MR, Kirollos RW, Santarius T.

Acta Neurochir (Wien). 2017 Nov;159(11):2169-2177. doi: 10.1007/s00701-017-3277-y. Epub 2017 Aug 9.

PMID:
28791500
17.

5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.

Widhalm G, Wolfsberger S, Minchev G, Woehrer A, Krssak M, Czech T, Prayer D, Asenbaum S, Hainfellner JA, Knosp E.

Cancer. 2010 Mar 15;116(6):1545-52. doi: 10.1002/cncr.24903.

18.

Conservative management of presumed low-grade gliomas in the asymptomatic pediatric population.

Ali ZS, Lang SS, Sutton LN.

World Neurosurg. 2014 Feb;81(2):368-73. doi: 10.1016/j.wneu.2013.01.038. Epub 2013 Jan 12.

PMID:
23321383
19.

Radiology reporting of low-grade glioma growth underestimates tumor expansion.

Gui C, Lau JC, Kosteniuk SE, Lee DH, Megyesi JF.

Acta Neurochir (Wien). 2019 Mar;161(3):569-576. doi: 10.1007/s00701-018-03783-3. Epub 2019 Feb 13.

PMID:
30756242
20.

Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.

Keles GE, Lamborn KR, Berger MS.

J Neurosurg. 2001 Nov;95(5):735-45. Review.

PMID:
11702861

Supplemental Content

Support Center